Aureus Research Consultants, LLC Aureus Research Consultants targets specialized-areas such as Phase I clinical trials, Oncology site networks, and Investigator-Initiated studies. We also perform audits for those Sponsors assuming INDs from former...
Auditing
Our 12 years of service to over 20 of the largest, global pharmaceutical, device and biotechnology organizations illustrate our experience across a range of...
REMETREX Incorporated. REMETREX was Incorporated is a privately-held corporation since its start in 1991.
REMETREX Incorporated is a privately-held corporation since its start in 1991.
REMETREX offers direct contact with the people who know...
AUDIT MANAGEMENT
REMETREX Safety AE is a web-based, enterprise level adverse event management system, designed for seamless data integration and linking with REMETREX PQ...
Averion Inc Averion International Corp. (Averion) is a leading international clinical research organization (CRO) with proven expertise in supporting global clinical trials for pharmaceutical, biotechnology and medical device...
When Performance Management Worlds Collide, Business Will Benefit is provided by the firm AMR Research and asks the question, how can companies drive world-class performance? This white paper posits that merging financial, operational, and personal metrics into one performance management system is the way for organizations to achieve Breakthrough Improvement. Also included is a brief case study ...
An exclusive interview with Steven Burrill By Cliff Mintz
G. Steven Burrill has devoted his entire career to helping life sciences compa- nies start up operations and sustain their growth. In 1994, he started Burrill & Company — a venture capital (VC), private equity, merchant banking, and media life sciences firm. The Burrill family of life sciences venture capital funds now manages more than ...
Ahura Scientific collaborated with an independent research organization that specializes in return on investment (ROI) and cost-benefit analysis to perform an objective study of the financial returns generated by the use of TruScan™. The organization examined the ROI and benefits TruScan offered under scenarios that are representative of the primary challenges facing the manufacturing and supply ...
“Which product in a class should be on formulary?” “What are the economic benefits and risks to adding a product to Tier 2?” Managed care organizations (MCOs) have numerous decisions to make each day. Many of these impact their bottom line. Therefore, it is necessary for the information being used to make the decisions be correct and presented in a fashion that is easy to understand. ...
Pharmaceutical, contract pharmaceutical manufacturing, and consumer packaged goods (CPG) production facilities face mounting pressure to increase productivity, maintain or increase quality control, and hold down costs. TruScan™, a handheld analyzer for non-contact identification of materials at the loading dock or in the warehouse, has enabled manufacturing and quality control managers to meet ...
Medical Device Manufacturers have always focused on bringing innovative high quality products to market. Yet shifting financial, regulatory and globalization landscapes call for closed-loop product management strategies that can keep up with the increasing innovation tempo and complexity of medical devices while at the same time, lower cost, increase quality, and facilitate compliance with ...
Moving Beyond Compliance: Reinvention of Enterprise Risk Management
Today’s companies are facing significant chal- lenges in balancing all the regulatory pressures coming from a long list of regulatory agencies from corporate and financial such as SEC, DOJ, CBP, ICE, BIS and OFAC, to operational and product areas such as the FDA, EMA, EPA, ISO and more. Many of these programs are still ...
The current financial crisis, increasing global competition, and near patent expiry of several multibillion dollar drugs is fundamentally reshaping the pharmaceutical industry. As consolidation in the industry continues through merger and acquisitions, companies are being forced to examine new strategies to cut costs and improve efficiencies to adapt to new financial realities. To that end, ...
Biotech was “born” in the 1970s. Since that time innovation by biotech pioneers has brought more than 200 medicines and vaccines to fruition for difficult-to-treat indications including oncology, HIV/ AIDs, diabetes, and immune disorders.
Biotech is poised to capitalize on the current challenges confronting Big Pharma: looming patent expirations on blockbuster medicines and a dearth of new ...
Throughout the economic downturn of 2008 and 2009, which dramatically impacted IT service spending, the Business Intelligence (BI) market remained a bright spot. In fact, many vendors experienced double-digit or even triple-digit growth of BI-related services in 2009, while experiencing revenue declines through the remainder of their portfolios.
Challenging economic times have created the need ...
StudyManager Reveal offers groundbreaking ease-of-use, power, and flexibility. Combining the latest web technology with 15 years of customer feedback, ...
Company descriptions and contact
information are quoted
from the company's website or other promotional information. JAZ'D is not responsible for
the accuracy
of this information. Unless specifically noted, JAZ'D is not sponsored by, affiliated with
or otherwise
connected with any of the listed companies.
